BRPI1003783A2 - Meio de cultura de células de mamíferos que compreende sobrenadante de estágios de fracionamento de cohn, seu processo de preparação e uso - Google Patents

Meio de cultura de células de mamíferos que compreende sobrenadante de estágios de fracionamento de cohn, seu processo de preparação e uso Download PDF

Info

Publication number
BRPI1003783A2
BRPI1003783A2 BRPI1003783-7A BRPI1003783A BRPI1003783A2 BR PI1003783 A2 BRPI1003783 A2 BR PI1003783A2 BR PI1003783 A BRPI1003783 A BR PI1003783A BR PI1003783 A2 BRPI1003783 A2 BR PI1003783A2
Authority
BR
Brazil
Prior art keywords
mammalian cell
cell culture
fractioning
cohn
supervisor
Prior art date
Application number
BRPI1003783-7A
Other languages
English (en)
Inventor
Ignacio Jorquera Nieto Juan
Costa Rierola Montserrat
Maria Diez Cervantes José
Original Assignee
Grifols, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42543450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1003783(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols, S.A. filed Critical Grifols, S.A.
Publication of BRPI1003783A2 publication Critical patent/BRPI1003783A2/pt
Publication of BRPI1003783B1 publication Critical patent/BRPI1003783B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0056—Xeno-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MEIO DE CULTURA DE CéLULAS DE MAMìFEROS QUE COMPREENDE SOBRENADANTE DE ESTáGIOS DE FRACIONAMENTO DE COHN, SEU PROCESSO DE PREPARAçãO E USO. A presente invenção refere-se aos meios de cultura de células de mamífero que compreendem sobrenadante de algumas das frações do fracionamento de plasma humano de acordo com o método de Gohn, mais especificamente, o sobrenadante das frações I e II + III. Quando o dito sobrenadante é adicionado como um suplemento do meio de cultura, fornece vários nutrientes e fatores para a manutenção e/ou a proliferação efetiva de culturas de células de mamíferos. Além disso, a presente invenção refere-se ao processo de preparação e utilização do referido meio de cultura de células de mamíferos.
BRPI1003783-7A 2009-07-28 2010-06-29 Meio de cultura de células de mamíferos que compreende sobrenadante de estágios de fracionamento de cohn, e seu processo de preparação in vitro BRPI1003783B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200930526 2009-07-28
ES200930526A ES2360782B1 (es) 2009-07-28 2009-07-28 Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.

Publications (2)

Publication Number Publication Date
BRPI1003783A2 true BRPI1003783A2 (pt) 2012-03-20
BRPI1003783B1 BRPI1003783B1 (pt) 2019-05-28

Family

ID=42543450

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1003783-7A BRPI1003783B1 (pt) 2009-07-28 2010-06-29 Meio de cultura de células de mamíferos que compreende sobrenadante de estágios de fracionamento de cohn, e seu processo de preparação in vitro

Country Status (17)

Country Link
US (1) US8252590B2 (pt)
EP (3) EP3059305B1 (pt)
JP (1) JP5265626B2 (pt)
CN (2) CN102660496A (pt)
AR (1) AR077217A1 (pt)
AU (1) AU2010202675B2 (pt)
BR (1) BRPI1003783B1 (pt)
CA (2) CA2708051C (pt)
CL (2) CL2010000774A1 (pt)
ES (4) ES2360782B1 (pt)
HU (2) HUE030817T2 (pt)
MX (1) MX2010007043A (pt)
NZ (1) NZ586917A (pt)
PL (3) PL2284254T3 (pt)
PT (3) PT3059305T (pt)
RU (1) RU2461629C2 (pt)
UY (1) UY32732A (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2890779B1 (en) 2012-08-31 2017-10-04 The Governors of the University of Alberta Methods for producing cells having a phenotype of primary human hepatocytes and compositions
CA2886726C (en) * 2012-10-03 2021-11-23 Csl Behring Llc A method of purifying proteins
US8835175B2 (en) * 2012-11-13 2014-09-16 Grifols, S.A. Culture medium for human mesenchymal stem cells
EP3143130B1 (en) * 2014-05-16 2024-03-06 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
US10563164B1 (en) 2015-10-08 2020-02-18 Charm Sciences, Inc. Plate reader
US10495563B1 (en) 2016-04-28 2019-12-03 Charm Sciences, Inc. Plate reader observation methods and operation
EP3571290B1 (en) 2017-01-23 2024-04-10 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells
EP3696260A1 (en) * 2019-02-15 2020-08-19 Grifols Worldwide Operations Limited Composition for improving the culture and implantation of mammalian embryos, preparation method and use thereof
CN113567678A (zh) * 2020-04-28 2021-10-29 信达生物制药(苏州)有限公司 一种评估培养基干粉稳定性的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1177424A (en) 1980-09-26 1984-11-06 Una S. Ryan Composition for cell culture
GB8331803D0 (en) * 1983-11-29 1984-01-04 Macleod A J Preparing component of cell growth medium
FR2572093A1 (fr) * 1984-10-22 1986-04-25 Anda Biolog Nouveau milieu de culture cellulaire contenant des cellules de rate humaine, procede de culture utilisant ce milieu de culture, lignees de cellules lymphoblastoides obtenues, application a la production d'interferon, procede de preparation d'interferon et interferon ainsi produit
CA1279593C (en) * 1985-05-10 1991-01-29 Makram Melek Girgis Cholesterol-rich fraction, process therefor and use thereof in cell culture
JPS63185376A (ja) * 1986-10-10 1988-07-30 インスティチュート・オブ・モレキュラー・バイオロジー・インコーポレーテッド コーン上清のフラクションvから製造される細胞培養メディウム
EP0440509A3 (en) 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
RU2020153C1 (ru) * 1991-01-17 1994-09-30 Научно-производственный центр медицинской биотехнологии Способ получения ферментативного гидролизата и питательная среда для культивирования клеток эукариотов
WO1994018310A1 (en) * 1993-02-12 1994-08-18 Baxter International Inc. Growth enhancing media supplement for the culture of mammalian cells
EP1975177B1 (en) * 1996-03-01 2011-04-13 Novo Nordisk A/S An appetite-suppressing peptide, its compositions and use
CN1723277A (zh) 2002-12-13 2006-01-18 赛罗哥斯公司 培养基组合物、培养方法和获得的成肌细胞及其应用
US20090075355A1 (en) 2004-11-19 2009-03-19 Koji Suzuki Human serum for cell culture

Also Published As

Publication number Publication date
CA2708051C (en) 2017-02-28
PT2284254T (pt) 2017-05-02
CA2708051A1 (en) 2011-01-28
ES2360782A1 (es) 2011-06-09
US20110027891A1 (en) 2011-02-03
JP2011024576A (ja) 2011-02-10
UY32732A (es) 2011-02-28
ES2624551T3 (es) 2017-07-14
PT2826854T (pt) 2017-03-01
US8252590B2 (en) 2012-08-28
CN102660496A (zh) 2012-09-12
CN101985611B (zh) 2013-07-17
CL2013000893A1 (es) 2014-03-07
EP3059305A1 (en) 2016-08-24
NZ586917A (en) 2012-02-24
PL3059305T3 (pl) 2018-11-30
BRPI1003783B1 (pt) 2019-05-28
HK1151313A1 (en) 2012-01-27
AU2010202675B2 (en) 2012-08-30
RU2010131632A (ru) 2012-02-10
PL2826854T3 (pl) 2017-07-31
AU2010202675A1 (en) 2011-02-17
ES2619324T3 (es) 2017-06-26
AR077217A1 (es) 2011-08-10
EP2284254B1 (en) 2017-03-29
CA2911575A1 (en) 2011-01-28
CA2911575C (en) 2017-02-14
HUE039008T2 (hu) 2018-12-28
HUE030817T2 (en) 2017-06-28
JP5265626B2 (ja) 2013-08-14
PT3059305T (pt) 2018-07-26
ES2360782B1 (es) 2012-03-12
CN101985611A (zh) 2011-03-16
EP2826854A1 (en) 2015-01-21
EP3059305B1 (en) 2018-07-11
MX2010007043A (es) 2011-01-27
RU2461629C2 (ru) 2012-09-20
PL2284254T3 (pl) 2017-07-31
ES2683269T3 (es) 2018-09-25
EP2284254A1 (en) 2011-02-16
CL2010000774A1 (es) 2011-05-27
EP2826854B1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
BR112016014488A2 (pt) Meio para cultura celular
BR112013002811A8 (pt) meios básicos simplificados para cultura celular pluripotente de humano
SG195299A1 (en) Expansion of stem cells in hollow fiber bioreactors
AR077217A1 (es) Medios para cultivo de celulas de mamiferos que comprenden sobrenadante de etapas del fraccionamiento de cohn y uso de los mismos
ES2523998T3 (es) Método de aislamiento de citoblastos dérmicos
BR112013027307A2 (pt) método para tratar uma matriz de tecido; matriz de tecido acelular
MX387489B (es) Cultivo de células de mamífero.
EP4372081C0 (en) MANUFACTURE AND USE OF AN IN VITRO SYNTHESIZED SSRNA FOR INTRODUCTION INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT
MX2012008388A (es) Microorganismos productores de acido eicosapentenoico, composiciones de acido graso, y metodos de elaboracion y usos de los mismos.
MX351174B (es) Microorganismos que producen acido eicosapentaenoico, composiciones de acidos grasos,y metodos para prepararlos y usos de los mismos.
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
EP4517321A3 (en) Method of nociceptor differentiantion of human embryonic stem cells and uses thereof
MX2015007361A (es) Produccion mediada por la proteina portadora de acilo de los derivados de acidos grasos.
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
BR112013032320A2 (pt) método e composição de produção de butanol, composição de butanol e isobutanol, método de cultivo de um micro-organismo produtor de butanol em material lignocelulósico e método para inibir o crescimento de micro-organismos que não produzem butanol em uma composição
MX2011009105A (es) Fraccionamiento de biomasa de algas.
BR112015017174A2 (pt) preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico
BR112017003990A2 (pt) processo para aumentar a produção de biomassa e esporos de bactéria que promove o crescimento de planta do gênero bacillus
SG178914A1 (en) Stem cell conditioned medium compositions
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
BR112014006244A2 (pt) microrganismos e métodos para produzir alcenos
BR112014013370A2 (pt) métodos de preparo de um catalisador
BR112014026206A2 (pt) sistemas e métodos celulares para melhorar a síntese de ácidos graxos através da expressão da desidrogenase
BR112013004616A2 (pt) diferenciação das células tronco embrionárias humanas

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/06/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/06/2010, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.